2415 — MedSci Healthcare Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$689.87m
- -HK$664.52m
- CNY270.37m
Annual income statement for MedSci Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 298 | 349 | 349 | 261 | 270 |
| Cost of Revenue | |||||
| Gross Profit | 190 | 206 | 217 | 162 | 160 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 445 | 445 | 288 | 235 | 251 |
| Operating Profit | -147 | -95.9 | 60.7 | 25.6 | 19.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -147 | -96.3 | 60.5 | 25.5 | 19.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -151 | -99.9 | 55 | 25 | 17.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -151 | -99.9 | 55 | 25 | 17.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -151 | -99.9 | 55 | 25 | 17.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.248 | -0.126 | 0.129 | 0.046 | 0.033 |
| Dividends per Share |